Pablo Vidal-Ribas Belil

Dr. Pablo Vidal-Ribas Belil

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
PBPablo Vidal-Ribas Belil
Pablo Vidal-Ribas Belil
MBMelissa A. Brotman
Melissa A. Brotman
IVIsabel Valdivieso
Isabel Valdivieso
ELEllen Leibenluft
Ellen Leibenluft
ASArgyris Stringaris
Argyris Stringaris
Research and clinical interest in irritability have been on the rise in recent years. Yet several questions remain about the status of irritability in psychiatry, including whether irritability can be differentiated from other symptoms, whether it forms a distinct disorder, and whether it is a meaningful predictor of clinical outcomes. In this article, we try to answer these questions by reviewing the evidence on how reliably irritability can be measured and its validity. We combine a narrative and systematic review and meta-analysis of studies. For the systematic review and meta-analysis, we searched studies in PubMed and Web of Science based on preselected criteria. A total of 163 articles were reviewed, and 24 were included. We found that irritability forms a distinct dimension with substantial stability across time, and that it is specifically associated with depression and anxiety in longitudinal studies. Evidence from genetic studies reveals that irritability is moderately heritable, and its overlap with depression is explained mainly by genetic factors. Behavioral and neuroimaging studies show that youth with persistent irritability exhibit altered activations in the amygdala, striatum, and frontal regions compared with age-matched healthy volunteers. Most knowledge about the treatment of irritability is based on effects of treatment on related conditions or post hoc analyses of trial data. We identify a number of research priorities including innovative experimental designs and priorities for treatment studies, and conclude with recommendations for the assessment of irritability for researchers and clinicians.

1 December 2015 in American Journal of Psychiatry
Verified
Journal Article
Closed access
ASArgyris Stringaris
Argyris Stringaris
PBPablo Vidal-Ribas Belil
Pablo Vidal-Ribas Belil
EAEric Artiges
Eric Artiges
HLHervé Lemaitre
Hervé Lemaitre
FGFanny Gollier-Briant
Fanny Gollier-Briant
ICIMAGEN Consortium
IMAGEN Consortium

30 October 2017 in Journal of Child Psychology and Psychiatry
Verified
Journal Article
Open access
PDF file
ASArgyris Stringaris
Argyris Stringaris
PBPablo Vidal-Ribas Belil
Pablo Vidal-Ribas Belil
MBMelissa A. Brotman
Melissa A. Brotman
ELEllen Leibenluft
Ellen Leibenluft
Background: Irritability is one of the most common reasons for referral to child and adolescent mental health services and is the main characteristic of the new diagnosis of disruptive mood dysregulation disorder ( DMDD ). However, the recognition and management of irritability presents a major challenge in clinical practice and may be partly responsible for the dramatic increase in antipsychotic prescribing in recent years. Methods: In this review, we provide up‐to‐date information on the definition and mechanisms underlying irritability, and its assessment in clinical practice. We aim to discuss the latest research on DMDD , and the presence of severe irritability in the context of other disorders, as well as to recommend a treatment algorithm. Results: Severe irritability is associated with aberrant reward processing and bias toward threatening stimuli. Several measures are available to easily assess irritability. The recent diagnosis of DMDD captures children whose main problem is severe irritability and differ from those with bipolar disorder in longitudinal outcomes, family history, and behavioral and neural correlates. Treatment of irritability might depend on the context it appears. Indirect evidence suggests that parent management training ( PMT ) and cognitive behavioral therapy ( CBT ) are the most supported psychological treatments for irritability. Conclusions: Irritability, recognized as a mood problem rather than a purely behavioral manifestation, is a common condition for young people. Practitioners should not ignore irritability as it is associated with substantial morbidity and impairment. Although there are no trials with irritability as main outcome, clinicians can apply several existing pharmacological and psychological interventions for its treatment. Also, new promising approaches relying on pathophysiological findings, such as exposure‐based cognitive behavioral therapy techniques and interpretation bias training ( IBT ), are being currently investigated.

1 January 2021 in Biological Psychiatry
Verified
Journal Article
Open access
DNDylan M. Nielson
Dylan M. Nielson
HKHanna Keren
Hanna Keren
GOGeorgia O’cAllaghan
Georgia O’cAllaghan
SJSarah M. Jackson
Sarah M. Jackson
IDIoanna Douka
Ioanna Douka
ASArgyris Stringaris
Argyris Stringaris
Both human and animal studies support the relationship between depression and reward processing abnormalities, giving rise to the expectation that neural signals of these processes may serve as biomarkers or mechanistic treatment targets. Given the great promise of this research line, we scrutinized those findings and the theoretical claims that underlie them. To achieve this, we applied the framework provided by classical work on causality as well as contemporary approaches to prediction. We identified a number of conceptual, practical, and analytical challenges to this line of research and used a preregistered meta-analysis to quantify the longitudinal associations between reward processing abnormalities and depression. We also investigated the impact of measurement error on reported data. We found that reward processing abnormalities do not reach levels that would be useful for clinical prediction, yet the available evidence does not preclude a possible causal role in depression.

23 May 2019 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
KTKenneth Towbin
Kenneth Towbin
PBPablo Vidal-Ribas Belil
Pablo Vidal-Ribas Belil
MBMelissa A. Brotman
Melissa A. Brotman
APAndrew Pickles
Andrew Pickles
KMKatherine V. Miller
Katherine V. Miller
ASArgyris Stringaris
Argyris Stringaris

1 April 2021 in Child and Adolescent Psychiatric Clinics of North America
Verified
Journal Article
Closed access
PBPablo Vidal-Ribas Belil
Pablo Vidal-Ribas Belil
ASArgyris Stringaris
Argyris Stringaris